Recognition of cytoplasmic yeast antigens of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattii by immune human sera

FEMS Immunology and Medical Microbiology

Volumn 17, Issue 2, 1997, Pages 111-119

  Hamilton, Andrew John ^a   Figueroa, Jose Ignacio ^a   Jeavons, Lisa ^a   Seaton, Ronald Andrew ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b King's Cross Hospital   (United Kingdom)

Author keywords

Cryptococcus neoformans; Immune sera recognition

Indexed keywords

FUNGUS ANTIGEN; IMMUNOGLOBULIN G;

ANTIBODY RESPONSE; ARTICLE; CLINICAL ARTICLE; CRYPTOCOCCUS NEOFORMANS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; PRIORITY JOURNAL; SERODIAGNOSIS;

ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; BLOTTING, WESTERN; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; ISOELECTRIC FOCUSING; MALE; SEROTYPING;

EID: 0031039290     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(96)00113-7     Document Type: Article

References (26)

1. Bhattacharjee, A.K., Bennett, J.E. and Glaudemans, C.P. (1984) Capsular polysaccharides of Cryptococcus neoformans. Rev. Infect. Dis. 6, 619-624.
2. Cherniak, R. (1988) Soluble polysaccharides of Cryptococcus neoformans. Curr. Top. Med. Mycol. 2, 40-54.
3. Evans, E.E. (1950) The antigenic composition of Cryptococcus neoformans. I. A serologic classification by means of the capsular agglutinations. J. Immunol. 64, 423-430.
4. Wilson, D.E., Bennett, J.E., and Bailey, J.W. (1968) Serologic grouping of Cryptococcus neoformans. Proc. Soc. Exp. Biol. Med. 127, 820-823.
5. Ellis, D.H., and Pfeiffer, T.J. (1990) Natural habitat of Cryptococcus neoformans var. gattii. J. Clin. Microbiol. 28, 1642-1644.
6. Emmons, C.W. (1955) Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia). Am. J. Hyg. 62, 227-232.
7. Kwon-Chung, K.J., Polacheck, I., and Popkin, T. (1982) Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotype A and D) and Cryptococcus neoformans var. gattii (serotype B and C). J. Clin. Microbiol. 15, 535-537.
8. Kwon-Chung, K.J., Wickes, B.L., Booth, J.L, Vishniac, H.S. and Bennett, J.E. (1987) Urease inhibition by EDTA in the two varieties of Cryptococcus neoformans. Infect. Immunol. 55, 1751-1754.
9. Brandt, M.E., Hutwagner, L.C., Kuykendall, R.J. and Pinner, R.W. (1995) Comparison of multilocus enzyme electrophoresis and random amplified polymorphic DNA analysis for molecular subtyping of Cryptococcus neoformans. The Cryptococcal disease active surveillance group. J. Clin. Microbiol. 33, 1890-1895.
10. Meyer, W., Mitchell, T.G., Freedman, E.Z, and Vilgalys, R. (1993) Hybridization probes for conventional DNA fingerprinting used as single primers in the polymerase chain reaction to distinguish strains of Cryptococcus neoformans. J. Clin. Microbiol. 31, 2274-2280.
11. Lalloo, D., Fisher, D., Naraqi, S., Laurenson, I., Temu, P., Sinha, A., Saweri, A. and Mavo, A. (1994) Cryptococcal meningitis (C. neoformans var. gattii) leading to blindness in previously healthy Melanesian adults in Papua New Guinea. Q. J. Med. 87, 343-349.
12. Mitchell, D.H., Sorrell, T.C, Allworth, A.M., Heath, C.H., McGregor, A.R., Papanaoum, K., Richards, M.J. and Gottlieb, T. (1995) Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin. Infect. Dis. 20, 611-616.
13. Speed, B. and Dunt, D. (1995) Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin. Infect. Dis. 21, 28-36.
14. Casadevall, A. (1995) Antibody immunity and invasive fungal infections. Infect. Immun. 63, 4211-4218.
15. Kwon-Chung, K.J. and Bennett, J.E. (1992) Cryptococcosis p.397-446. In: Kwon-Chung K.J. and Bennett J.E. (Ed.), Medical Mycology. Lea and Febiger, Philadelphia and London.
16. Hamilton, A.J., Bartholomew, M.A., Figueroa, J.I., Fenelon, L.E. and Hay, R.J. (1991) Production of species-specific murine monoclonal antibodies against Cryptococcus neoformans which recognize a non-capsular exoantigen. J. Clin. Microbiol. 29, 980-984.
17. Hamilton A.J. and Goodley J. (1993) Purification of the 115-kilodalton exoantigen of Cryptococcus neoformans and its recognition by human immune sera. J. Clin. Microbiol. 31, 335-339.
18. Read S.M., and Northcote D.H. (1981) Minimization of variation in the response to different proteins in the Coomassie blue G dye-binding assay for protein. Anal. Biochem. 116, 53-64.
19. Figueroa J.I., Hamilton A.J, Allen M.H, and Hay R.J. (1995) Isolation and partial characterisation of a Paracoccidioides brasiliensis 58kDa extracellular glycoprotein which is recognised by human immune sera. Trans. R. Soc. Trop. Med. Hyg. 89, 566-572.
20. Hamilton A.J., Bartholomew M.A., Fenelon L.E., Figueroa J.I. and Hay R.J. (1990) A murine monoclonal antibody exhibiting high species specificity for Histoplasma capsulatum var. capsulatum. J. Gen. Micro. 136, 331-335.
21. Hamilton A.J., Jeavons L., Hobby P. and Hay R.J. (1992) A 34- to 38-kilodalton Cryptococcus neoformans glycoprotein produced as an exoantigen bearing a glycosylated species-specific epitope. Infect. Immunol. 60, 143-149.
22. Seaton R.A., Hamilton A.J., Hay R.J., and Warrell D.A. (1996) Exposure to Cryptococcus neoformans var. gattii - a seroepidemiological study. Trans. R. Soc. Trop. Med. Hyg., in press.
23. Hamilton A.J., Bartholomew M.A., Figueroa J.I., Fenelon L.E., and Hay R.J. (1991) Murine monoclonal antibodies recognising a non-capsular antigen that distinguishes between Cryptococcus neoformans var. neoformans and C. neoformans var. gattii. Trans. R. Soc. Trop. Med. Hyg. 86, 123-127.
24. Matthews R.C. (1996) Comparative assessment of the detection of candidal antigens as a diagnostic tool. J. Med. Vet. Mycol. 34, 1-10.
25. Gomez F.J., Allendorfer R. and Deepe G.S. (1995) Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect. Immunol. 63, 2587-2595.
26. Deshaw M., and Pirofski L.-A. (1995) Antibodies to the Cryptococcus neoformans capsular glucuronoxylomannan are ubiquitous in serum from HIV+ and HIV- individuals. Clin. Exp. Immunol. 99, 425-432.